Both in Biotechnology
Estrella Immunopharma vs BioCardia
Over the past year ESLA returned −66.7% and BCDA returned −30.8%; their daily moves had a correlation of 0.12.
ESLA −66.7% BCDA −30.8%Growth of $1, one year, split-adjusted
| Metric | ESLA | BCDA |
|---|---|---|
| Price | $0.8217 | $0.9474 |
| Market cap | $35.7M | $14.3M |
| Today | −11.86% | +2.81% |
| 1 month | +78.6% | −8.0% |
| 6 months | −44.1% | −13.9% |
| Year to date | −47.3% | −24.2% |
| 1 year | −64.0% | −27.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $146.7K | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 180.5% | 67.6% |
| Short % of float | 4.0% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).